Semaglutide study to see how brown fat responds in weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how brown fat (a type of body fat) changes after starting semaglutide for weight loss. You may help researchers understand how this medication affects the body’s energy use, which could improve weight-loss treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to start semaglutide for weight loss, and the study won’t provide or pay for it
- You’re over 18 years old and willing to participate
- You are male, or you are a post-menopausal female
- You have never had neck surgery and/or neck radiation (for example, treatment for cancer)
- You can’t be taking beta blockers or any other medicines that lower blood sugar
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brown fat affects weight loss with the medication semaglutide (Wegovy). If you are starting semaglutide for obesity, this trial may help understand if it will work better for you.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.